rs1042395

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The highest continental population minor allele frequency for c.668G>A (p.Arg223His) in gnomAD v2.1.1 is 0.74034 in the European non-Finnish population. This is higher than the ClinGen LSD VCEP’s BA1 threshold (>0.01), therefore meeting the BA1 criterion. There is a ClinVar entry for this variant (Variation ID: 92488; 2 star review status) with six submitters classifying the variant as benign, and one as likely benign. In summary, this variant meets the criteria to be classified as benign for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LSD VCEP: BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA145791/MONDO:0009290/010

Frequency

Genomes: 𝑓 0.66 ( 33595 hom., cov: 33)
Exomes 𝑓: 0.71 ( 369171 hom. )

Consequence

GAA
NM_000152.5 missense

Scores

1
2
15

Clinical Significance

Benign reviewed by expert panel U:1B:16

Conservation

PhyloP100: -0.0360
Variant links:
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAANM_000152.5 linkc.668G>A p.Arg223His missense_variant Exon 3 of 20 ENST00000302262.8 NP_000143.2 P10253

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAAENST00000302262.8 linkc.668G>A p.Arg223His missense_variant Exon 3 of 20 1 NM_000152.5 ENSP00000305692.3 P10253

Frequencies

GnomAD3 genomes
AF:
0.657
AC:
99833
AN:
151982
Hom.:
33582
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.536
Gnomad AMI
AF:
0.649
Gnomad AMR
AF:
0.559
Gnomad ASJ
AF:
0.770
Gnomad EAS
AF:
0.539
Gnomad SAS
AF:
0.658
Gnomad FIN
AF:
0.775
Gnomad MID
AF:
0.839
Gnomad NFE
AF:
0.736
Gnomad OTH
AF:
0.667
GnomAD3 exomes
AF:
0.666
AC:
162329
AN:
243594
Hom.:
55735
AF XY:
0.681
AC XY:
90323
AN XY:
132592
show subpopulations
Gnomad AFR exome
AF:
0.538
Gnomad AMR exome
AF:
0.474
Gnomad ASJ exome
AF:
0.779
Gnomad EAS exome
AF:
0.528
Gnomad SAS exome
AF:
0.669
Gnomad FIN exome
AF:
0.752
Gnomad NFE exome
AF:
0.740
Gnomad OTH exome
AF:
0.720
GnomAD4 exome
AF:
0.711
AC:
1030164
AN:
1448490
Hom.:
369171
Cov.:
58
AF XY:
0.712
AC XY:
512807
AN XY:
720028
show subpopulations
Gnomad4 AFR exome
AF:
0.539
Gnomad4 AMR exome
AF:
0.489
Gnomad4 ASJ exome
AF:
0.782
Gnomad4 EAS exome
AF:
0.559
Gnomad4 SAS exome
AF:
0.670
Gnomad4 FIN exome
AF:
0.760
Gnomad4 NFE exome
AF:
0.730
Gnomad4 OTH exome
AF:
0.709
GnomAD4 genome
AF:
0.657
AC:
99875
AN:
152100
Hom.:
33595
Cov.:
33
AF XY:
0.654
AC XY:
48653
AN XY:
74362
show subpopulations
Gnomad4 AFR
AF:
0.536
Gnomad4 AMR
AF:
0.558
Gnomad4 ASJ
AF:
0.770
Gnomad4 EAS
AF:
0.539
Gnomad4 SAS
AF:
0.657
Gnomad4 FIN
AF:
0.775
Gnomad4 NFE
AF:
0.736
Gnomad4 OTH
AF:
0.667
Alfa
AF:
0.713
Hom.:
49456
Bravo
AF:
0.637
TwinsUK
AF:
0.723
AC:
2681
ALSPAC
AF:
0.724
AC:
2792
ESP6500AA
AF:
0.544
AC:
2396
ESP6500EA
AF:
0.738
AC:
6348
ExAC
AF:
0.675
AC:
81893
Asia WGS
AF:
0.580
AC:
2021
AN:
3476
EpiCase
AF:
0.742
EpiControl
AF:
0.742

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:16
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Glycogen storage disease, type II Benign:7
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jun 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 22, 2020
ClinGen Lysosomal Storage Disorder Variant Curation Expert Panel
Significance: Benign
Review Status: reviewed by expert panel
Collection Method: curation

The highest continental population minor allele frequency for c.668G>A (p.Arg223His) in gnomAD v2.1.1 is 0.74034 in the European non-Finnish population. This is higher than the ClinGen LSD VCEP's BA1 threshold (>0.01), therefore meeting the BA1 criterion. There is a ClinVar entry for this variant (Variation ID: 92488; 2 star review status) with six submitters classifying the variant as benign, and one as likely benign. In summary, this variant meets the criteria to be classified as benign for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LSD VCEP: BA1. -

Feb 18, 2015
Counsyl
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: literature only

- -

Nov 18, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Sep 04, 2018
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Uncertain:1Benign:3
Oct 19, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

multiple AR variants in same gene - keep for nowAllele frequency is common in at least one population database (frequency: 77.927% in gnomAD_ExomesFounderPop) based on the frequency threshold of 2.76% for this gene.Variant was observed in a homozygous state in population databases more than expected for disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Cardiovascular phenotype Benign:1
Dec 11, 2018
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
17
DANN
Benign
0.80
DEOGEN2
Uncertain
0.46
T;D;D
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.66
T;.;T
MetaRNN
Benign
0.000017
T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Pathogenic
3.3
.;M;M
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.6
.;N;N
REVEL
Uncertain
0.39
Sift
Benign
0.54
.;T;T
Sift4G
Benign
0.29
T;T;T
Polyphen
0.21
.;B;B
Vest4
0.050, 0.049
MPC
0.14
ClinPred
0.033
T
GERP RS
1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.23
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1042395; hg19: chr17-78079669; COSMIC: COSV56406846; COSMIC: COSV56406846; API